| AE | Adverse event |
| ATF4 | Activating transcription factor 4 |
| CDC | Complement-dependent cytotoxicity |
| cGAS-STING | Cyclic GMP-AMP synthase–stimulator of interferon genes |
| CLEC10A | C-type lectin domain-containing 10A |
| CRC | Colorectal cancer |
| CTL | Cytotoxic T lymphocyte |
| DAMPs | Damage-associated molecular patterns |
| DC | Dendritic cell |
| EGFR | Epidermal growth factor receptor |
| EIF2S1 | Eukaryotic translation initiation factor 2 subunit alpha |
| GM-CSF | Granulocyte–macrophage colony-stimulating factor |
| GZMK | Granzyme K |
| HCC | Hepatocellular carcinoma |
| HSV | Herpes simplex virus |
| HVR | Hexon hypervariable region |
| ICI | Immune checkpoint inhibitor |
| IFNγ | Interferon-γ |
| IL-12 | Interleukin-12 |
| IRF3 | Interferon regulatory factor 3 |
| MDSC | Myeloid-derived suppressor cell |
| MHC-I | Major histocompatibility complex class I |
| MPA | Metastatic pancreatic cancer |
| NAb | Neutralizing antibody |
| NK cells | Natural killer cells |
| NMIBC | Non-muscle-invasive bladder cancer |
| ORR | Objective response rate |
| OV | Oncolytic virus |
| PDAC | Pancreatic ductal adenocarcinoma |
| S100A1 | S100 calcium-binding protein A1 |
| STING | Stimulator of interferon gene |
| TAM | Tumor-associated macrophage |
| TAP | Transporter-associated peptide |
| TBK1 | TANK-binding kinase 1 |
| TIME | Tumor immune microenvironment |
| Treg cell | Regulatory T cell |
| TME | Tumor microenvironment |